Search for: "USA v. Rose" Results 101 - 120 of 162
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 May 2022, 4:05 pm by INFORRM
  The work has been comprehensively updated to take in the latest case including Lachaux, Stocker, Serafin, Lloyd v Google, Economou, Wright v Ver, Wright v Granath, Corbyn v Millett, Duchess of Sussex v Associated, and Soriano v Forensic News. [read post]
4 Sep 2014, 3:19 am by Kevin LaCroix
There was no discussion about when the risk of “potential incidents” rose to the level of disclosure. [read post]
2 Jun 2011, 12:46 pm by Bexis
Rose Drugs of Dardanelle, Inc., ___ S.W.3d ___, 2011 WL 478601, at *?? [read post]
23 Feb 2014, 6:01 pm by Joy Waltemath
Though not physically threatening, it “easily” rose to a physically humiliating level. [read post]
26 Sep 2022, 4:49 am by Dennis Crouch
Skinny Label Infringement in Teva Pharmaceuticals USA, Inc. v. [read post]
7 May 2014, 7:25 am by Joy Waltemath
His retaliation claim also failed because he could not show a causal link between his termination and his discrimination complaint a year earlier (Hnin v TOA (USA), LLC, May 5, 2014, St. [read post]
19 Oct 2016, 8:45 am by Victoria Kwan
On October 5, Breyer sat for a conversation with Charlie Rose at the 92nd Street Y in New York. [read post]
26 Feb 2011, 3:47 pm
Mayne Pharma (USA) Inc., 467 F.3d 1370, 1379 (Fed. [read post]
24 May 2022, 5:01 am by George Croner
After a slight dip in CY 2020, the number of targets rose again in CY 2021 to 232,432—the largest number since the ODNI began reporting § 702 targeting statistics in 2014 (Table 4). [read post]
24 May 2022, 5:01 am by George Croner
After a slight dip in CY 2020, the number of targets rose again in CY 2021 to 232,432—the largest number since the ODNI began reporting § 702 targeting statistics in 2014 (Table 4). [read post]